What are Guardant Health's total assets?

Guardant Health (GH) holds $1.9B in total assets, up 42.5% year over year.

How much debt does Guardant Health have?

Guardant Health carries $1.7B in total debt against -$181.1M of shareholders' equity, a debt-to-equity ratio of 3.03.

How much cash does Guardant Health have?

Guardant Health holds $1.1B in cash and equivalents.

Can Guardant Health cover its short-term obligations?

Its current ratio is 4.68 — current assets exceed current liabilities.

Where does Guardant Health's balance sheet data come from?

Every line is extracted from Guardant Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Guardant Health GH Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$489.42M-22.3%	$629.76M-44.5%	$1.13B+699%	$141.95M-71.2%
Short-term investments	$823.4M+162%	$314.44M+796%	$35.1M-96.0%	$869.58M+97.4%
Restricted cash	$111.21M+6.7%	$104.22M+69,377%	$150K-50.0%	$300K+200%
Accounts receivable, net	$137.85M+25.0%	$110.25M+24.2%	$88.78M-8.7%	$97.26M-0.4%
Inventories	$85.88M+20.8%	$71.08M+14.7%	$61.95M+20.1%	$51.6M+68.2%
Prepaid expenses and other current assets	$40.72M+20.5%	$33.8M+21.8%	$27.74M-12.0%	$31.51M-40.6%
Total current assets	$1.47B+38.9%	$1.06B-21.7%	$1.35B+13.1%	$1.19B+7.0%
Property and equipment, net	$145.92M+6.7%	$136.81M-5.7%	$145.1M-13.6%	$167.92M+34.9%
Accumulated depreciation	$198.9M+20.2%	$165.53M+30.0%	$127.31M+44.5%	$88.13M+60.8%
Operating lease right-of-use assets	4.5%-14,226,499,996%	14,226,500,000%-1,535,100,000%	15,761,600,000%-1,638,500,000%	17,400,100,000%-1,544,200,000%
Goodwill	$77.26M+2,248%	$3.29M0.0%	$3.29M0.0%	$3.29M0.0%
Intangible assets, net	$5.09M-24.7%	$6.76M-24.7%	$8.98M-23.4%	$11.73M-17.5%
Other non-current assets	$28.46M-23.4%	$37.15M-70.1%	$124.18M+102%	$61.45M+0.8%
Equity securities	$6.5M-59.6%	$16.1M+87.2%	$8.6M-65.6%	$25M-36.5%
Total assets	$2.01B+35.5%	$1.49B-16.8%	$1.79B+11.0%	$1.61B-27.0%
Accrued expenses	$77.89M+14.0%	$68.35M+7.7%	$63.48M-63.9%	$175.82M+288%
Accrued compensation	$119.65M+43.8%	$83.22M+14.4%	$72.74M+30.4%	$55.79M+31.3%
Deferred revenue	$50.75M+43.1%	$35.47M+97.4%	$17.97M+3.2%	$17.4M+53.7%
Operating lease liabilities, current	$27.68M-5.3%	$29.21M+4.5%	$27.95M+27.8%	$21.88M+70.2%
Contract liabilities	$9M+47.5%	$6.1M+22.0%	$5M+31.6%	$3.8M-66.4%
Total current liabilities	$302.73M+34.2%	$225.58M+9.6%	$205.92M+6.6%	$193.22M-0.8%
Long-term debt	$1.5B+31.6%	$1.14B—	——	——
Operating lease liabilities, non-current	$178.46M+8.6%	$164.29M-11.6%	$185.85M-11.5%	$210.02M-7.1%
Operating Lease Liabilities (Total)	$206.14M+6.5%	$193.51M-9.5%	$213.8M-7.8%	$231.89M-2.9%
Other non-current liabilities	$127.77M+37.6%	$92.83M-3.3%	$96.01M+946%	$9.18M+133%
Total liabilities	$2.11B+30.0%	$1.63B-0.2%	$1.63B+5.0%	$1.55B-0.6%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	$1K0.0%	$1K0.0%	$1K0.0%	$1K0.0%
Additional paid-in capital	$2.9B+18.7%	$2.44B+6.1%	$2.3B+32.3%	$1.74B+5.1%
Retained earnings	-$2.99B-16.1%	-$2.58B-20.4%	-$2.14B-28.8%	-$1.66B-65.0%
Accumulated other comprehensive income (loss)	-$4.85M+6.7%	-$5.2M-41.5%	-$3.68M+81.2%	-$19.52M-310%
Total stockholders' equity	-$99.31M+28.9%	-$139.65M-188%	$158.68M+164%	$60.18M-90.7%
Total liabilities and stockholders' equity	$2.01B+35.5%	$1.49B-16.8%	$1.79B+11.0%	$1.61B-27.0%
Available-for-Sale Debt Securities - Amortized Cost	$1.26B—	——	——	——
Cash, Cash Equivalents, and Marketable Securities	$1.26B—	——	——	$856.73M—
Available For Sale Securities Debt Securities Current	$823.4M+162%	$314.44M+796%	$35.1M-96.0%	$869.58M+97.4%
Accumulated Goodwill Impairment Losses	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$28.46M-23.4%	$37.15M-70.1%	$124.18M+102%	$61.45M+0.8%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Finite Lived Intangible Assets - Gross	$16.99M-8.6%	$18.59M0.0%	$18.59M0.0%	$18.59M+9.4%
Goodwill and Intangible Assets, Net	$103.18M+927%	$10.05M-18.1%	$12.27M-18.3%	$15.02M-14.2%
Investments - Amortized Cost Basis	$1.26B—	——	——	——
Net Investment in Lease	$158.85M+11.7%	$142.27M-9.7%	$157.62M-9.4%	$174M-8.2%
Intangible assets — net	$5.09M-24.7%	$6.76M-24.7%	$8.98M-23.4%	$11.73M-7.0%
Other intangible assets—net	$25.92M+283%	$6.76M-24.7%	$8.98M-23.4%	$11.73M-17.5%
Goodwill and intangible assets, net	$103.18M+927%	$10.05M-18.1%	$12.27M-18.3%	$15.02M-14.2%
Operating lease right-of-use assets	$158.85M+11.7%	$142.27M-9.7%	$157.62M-9.4%	$174M-8.2%
Other non-current assets	$28.46M-23.4%	$37.15M-70.1%	$124.18M+102%	$61.45M+0.8%
Property, plant and equipment at cost	$344.82M+14.0%	$302.34M+11.0%	$272.4M+6.4%	$256.05M+42.8%
Operating Lease Right-of-Use Assets in Other Assets	$158.85M+11.7%	$142.27M-9.7%	$157.62M-9.4%	$174M-8.2%
Software and Technology Licenses, Net	$28.46M-23.4%	$37.15M-70.1%	$124.18M+102%	$61.45M+0.8%
Accrued Progress Collections and Price Adjustments	$9M+47.5%	$6.1M+22.0%	$5M+31.6%	$3.8M—
Other Commercial Liabilities	$77.89M+14.0%	$68.35M+7.7%	$63.48M-63.9%	$175.82M+288%
Accrued Liabilities, Current	$77.89M+14.0%	$68.35M+7.7%	$63.48M-63.9%	$175.82M+288%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Contract Liabilities, Non-Current	$9M+47.5%	$6.1M+22.0%	$5M+31.6%	$3.8M—
Convertible Debt (Non-Current)	$1.5B+31.6%	$1.14B+0.2%	$1.14B+0.2%	$1.14B+0.2%
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Deferred revenue, net of current portion	$9M+47.5%	$6.1M+22.0%	$5M+31.6%	$3.8M—
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	130.6M+5.4%	124M+1.9%	121.6M+18.5%	102.6M+0.8%
Common Stock Shares Outstanding	$310.47M+763%	$35.98M-8.0%	$39.12M-1.6%	$39.75M-79.4%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Cumulative Gross Losses and Impairments	——	——	——	——
Number of Exercisable Options	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	4.5M-1.8%	4.6M+15.4%	4M+17.9%	3.4M+29.6%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——
Share Price	——	——	——	——
Shares Reserved for Future Issuance Under Stock Plans	28.2M+3.7%	27.1M+9.8%	24.7M+52.1%	16.2M+21.1%
Unrealized Gains on Investments	$130K-44.0%	$232K—	$0-100%	$8K+300%
Unrealized Losses on Investments (Before Tax)	$40K—	$0-100%	$11K-99.9%	$16.78M+367%
Weighted Average Exercise Price of Outstanding Options	$34.83+5.6%	$32.98+3.8%	$31.76-7.5%	$34.34+17.7%
Cumulative Cost Basis	$1.26B+316%	$302.34M+11.0%	$272.4M+6.4%	$256.05M+42.8%
Number of Class Action Lawsuits	——	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$40K—	$0-100%	$11K-99.9%	$16.78M+367%
Gross Unrealized Gains	$130K-44.0%	$232K—	$0-100%	$8K+300%
Total	$1.26B—	——	——	——
Available for sale investments	$1.26B—	——	——	——
Common stock, capital shares reserved for future issuance	$28.16M+3.7%	$27.15M+9.8%	$24.72M+52.1%	$16.25M+21.1%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$350M0.0%	$350M0.0%	$350M0.0%	$350M0.0%
Common stock, shares issued (in shares)	$130.64M+5.4%	$123.99M+1.9%	$121.63M+18.5%	$102.62M+0.8%
Common Stock, Shares, Outstanding	$130.64M+5.4%	$123.99M+1.9%	$121.63M+18.5%	$102.62M+0.8%
Contract with Customer, Asset, after Allowance for Credit Loss	$5.2M+52.9%	$3.4M-30.6%	$4.9M-9.3%	$5.4M-5.3%
Contract with Customer, Liability	$59.7M+43.5%	$41.6M+81.7%	$22.9M+8.0%	$21.2M+87.6%
Share price, premium	——	——	——	——
Strike price (in dollars per share)	——	——	——	——
Convertible debentures	$1.5B+31.6%	$1.14B+0.2%	$1.14B+0.2%	$1.14B+0.2%
Cost not yet recognized	——	——	——	——
2031 and thereafter	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$11.9M+0.6%	$11.83M+23.1%	$9.61M+40.1%	$6.86M+56.6%
2028	——	——	——	——
2030	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Gross Carrying Amount	$16.99M-8.6%	$18.59M0.0%	$18.59M0.0%	$18.59M+9.4%
Goodwill accumulated impairment losses	——	——	——	——
Indefinite-Lived Intangible Assets (Including Goodwill)	$98.09M—	——	——	——
Intangible Assets, Gross (Including Goodwill)	$115.07M+426%	$21.88M0.0%	$21.88M0.0%	$21.88M0.0%
Lessee Operating Lease Liability Payments Due	——	——	——	——
2031 and thereafter	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
Area of square feet leased	——	——	——	——
Number of class action complaints	——	——	——	——
Number of lawsuits with an additional claim	——	——	——	——
Number of investees deemed variable interest entity, not primary beneficiary	——	——	——	——
Number of revenue sources	——	——	——	——
Incremental borrowing rate	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	$0.05+17.8%	$0.04-1.3%	$0.04-1.5%	$0.04-2.0%
Other accrued liabilities	$50.21M+28.3%	$39.13M-38.4%	$63.48M+117%	$29.24M+274%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$4.55M-1.8%	$4.63M+15.4%	$4.01M+17.9%	$3.4M+29.6%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$34.83+5.6%	$32.98+3.8%	$31.76-7.5%	$34.34+17.7%
Incentive stock program, shares reserved for future grants (in shares)	$13.18M+9.9%	$12M-0.1%	$12M+121%	$5.44M+4.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$310.47M+763%	$35.98M-8.0%	$39.12M-1.6%	$39.75M-79.4%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Share price (in dollars per share)	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——
Shares Issued Price Per Share	$90.00—	——	$26.77—	——
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Guardant Health.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Guardant Health's total assets?: Guardant Health (GH) holds $1.9B in total assets, up 42.5% year over year.
How much debt does Guardant Health have?: Guardant Health carries $1.7B in total debt against -$181.1M of shareholders' equity, a debt-to-equity ratio of 3.03.
How much cash does Guardant Health have?: Guardant Health holds $1.1B in cash and equivalents.
Can Guardant Health cover its short-term obligations?: Its current ratio is 4.68 — current assets exceed current liabilities.
Where does Guardant Health's balance sheet data come from?: Every line is extracted from Guardant Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.